...
首页> 外文期刊>癌と化学療法 >An advanced aged case of intrapulmonary metastasis of non-small cell lung cancer successfully controlled with S-1 capsule therapy alone for an extended period
【24h】

An advanced aged case of intrapulmonary metastasis of non-small cell lung cancer successfully controlled with S-1 capsule therapy alone for an extended period

机译:单独使用S-1胶囊治疗可成功控制晚期老年非小细胞肺癌肺内转移

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The patient was an 84-year-old male. About 7 months after surgery for a non-small cell lung cancer StageIII B, granular shadows were noted on his bilateral lungs on CT; and the level of CA 19-9 , a tumor marker, had increased. These findings led to a diagnosis of intrapulmonary tumor metastasis. Treatment with a platinum-based antineoplastic agent was recommended,but the patient refused it because of his age. The patient was thus placed under observation. Because the tumor appeared to increase in size, treatment was initiated using S-1 capsules (hereafter abbreviated to S-1) alone. Each course consisted of S-1 at a dosage of 100 mg/body/day, twice daily for 21 days, followed by 14 days of drug withdrawal. After the completion of one course, the level of the tumor marker was reduced to normal. After 6 courses were completed, CT indicated a marked reduction or elimination of the intrapulmonary metastatic foci. Malignant phenomenon exceeding grade 3 was no longer recognized,and it was possible to deliver the scheduled dosage of S-1 throughout the entire series of courses. At the end of the 14th course, no signs of exacerbation or recurrence were recognized. It has been about 18 months after the S-1 single therapy was started. This therapy is still being continued.
机译:该患者是一名84岁的男性。在非小细胞肺癌StageIII B手术后约7个月,CT的双侧肺部出现了颗粒状阴影;并且肿瘤标记物CA 19-9的水平有所增加。这些发现导致了肺内肿瘤转移的诊断。建议使用铂类抗肿瘤药治疗,但患者由于年龄原因拒绝治疗。因此将患者置于观察之下。因为肿瘤看起来增大,所以仅使用S-1胶囊(以下缩写为S-1)开始治疗。每个疗程由剂量为100 mg /人/天的S-1组成,每天两次,持续21天,然后停药14天。在完成一个疗程后,肿瘤标志物的水平降至正常。完成6个疗程后,CT显示肺内转移灶明显减少或消失。不再认识到超过3级的恶性现象,并且有可能在整个系列课程中提供预定剂量的S-1。在第14疗程结束时,未发现病情加重或复发的迹象。 S-1单一疗法开始至今已约18个月。这种疗法仍在继续。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号